The document discusses the regulatory considerations for clinical trials that utilize AI, emphasizing the importance of transparency and compliance with data standards. It outlines the necessity for a regulatory impact assessment and the thoughtful use of AI tools to ensure the integrity of clinical data and patient safety.
The European Commission’s AI Office recently held a webinar to discuss the AI literacy requirement under the EU AI Act, which came into effect on February 2, 2025. The Act mandates that providers and deployers of AI systems ensure a sufficient level of AI literacy among their staff to effectively manage the opportunities and risks associated with AI.
The article discusses the emerging AI regulations in Nepal, highlighting the need for a robust framework that addresses data protection, privacy rights, and ethical safeguards. It emphasizes the importance of learning from global practices to ensure that AI tools are used responsibly, especially by state agencies like law enforcement.
On February 20, 2025, the Virginia General Assembly passed HB 2094, the Virginia High-Risk Artificial Intelligence Developer and Deployer Act, which awaits the signature of Governor Youngkin. If enacted, Virginia will become the second state to legislate against algorithmic discrimination, targeting high-risk AI systems that significantly impact consequential decision-making.
The EU AI Act establishes a regulatory framework for AI that requires businesses operating in Europe to meet new standards for transparency, data quality, and bias reduction. While compliance may seem challenging, it presents opportunities for enhanced AI literacy within finance teams, enabling better understanding and utilization of AI to support informed decision-making.
Take the first steps in your transformation towards international AI compliance.
Our expert sales team is here to answer your questions, just leave your email and we’ll get in touch.
